Expanscience

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40000314

Informations générales

Localisation

France

Europe

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

12/10/2023

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2030

Statut

Targets set

Classification

1.5°C

Année cible

2030

Progression vers l'objectif73%
2015 (année de référence)2030
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon 2050

Statut

Targets set

Classification

1.5°C

Année cible

2050

Progression vers l'objectif31%
2015 (année de référence)2050
Description complète des objectifs

Overall Net-Zero Target Expanscience commits to reach net-zero greenhouse gas emissions across the value chain by 2050. Near-Term Targets Expanscience commits to reduce absolute scope 1 and 2 GHG emissions 46.2% by 2030 from a 2019 base year. Expanscience commits to reduce absolute scope 3 GHG emissions from purchased goods and services, fuel and energy related activities, upstream transportation and distribution, business travel, employee commuting, downstream transportation, and end of life treatment of sold products 46.2% by 2030 from a 2019 base year. Long-Term Targets Expanscience commits to reduce absolute scope 1, 2, and 3 GHG emissions 90% by 2050 from a 2019 base year.

Net-Zero

Statut

Targets set

Année cible

2050

Progression31%
Business Ambition 1.5°C

Statut

BA1.5 member

Date d'engagement

27/10/2022

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

969500C4Z0KZ5S29WM22

Source : Science Based Targets initiative | Données publiques